SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1

Abstract

Sirtuins catalyze NAD؉ -dependent protein deacetylation and are critical regulators of transcription, apoptosis, metabolism, and aging. There are seven human sirtuins (SIRT1-7), and SIRT1 has been implicated as a key mediator of the pathways downstream of calorie restriction that have been shown to delay the onset and reduce the incidence of age-related diseases such as type 2 diabetes. Increasing SIRT1 activity, either by transgenic overexpression of the Sirt1 gene in mice or by pharmacological activation by small molecule activators resveratrol and SRT1720, has shown beneficial effects in rodent models of type 2 diabetes, indicating that SIRT1 may represent an attractive therapeutic target. Herein, we have assessed purported SIRT1 activators by employing biochemical assays utilizing native substrates, including a p53-derived peptide substrate lacking a fluorophore as well as the purified native full-length protein substrates p53 and acetyl-CoA synthetase1. SRT1720, its structurally related compounds SRT2183 and SRT1460, and resveratrol do not lead to apparent activation of SIRT1 with native peptide or full-length protein substrates, whereas they do activate SIRT1 with peptide substrate containing a covalently attached fluorophore. Employing NMR, surface plasmon resonance, and isothermal calorimetry techniques, we provide evidence that these compounds directly interact with fluorophorecontaining peptide substrates. Furthermore, we demonstrate that SRT1720 neither lowers plasma glucose nor improves mitochondrial capacity in mice fed a high fat diet. SRT1720, SRT2183, SRT1460, and resveratrol exhibit multiple off-target activities against receptors, enzymes, transporters, and ion channels. Taken together, we conclude that SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1.

Sirtuin 1 Is a Negative Regulator of Parathyroid Hormone Stimulation of Matrix Metalloproteinase 13 Expression in Osteoblastic Cells

“…We understand that there are controversial reports on resveratrol activating SIRT1 (45). However, there is a growing body of studies that have shown that the effects of resveratrol depend on SIRT1.…”

Dietary Interventions to Extend Life Span and Health Span Based on Calorie Restriction

“…screening compounds for their ability to activate sirtuins first led to the discovery of resveratrol as a potential CRM (74). Although emerging evidence suggests that resveratrol and other compounds may not directly activate sirt1, many beneficial health effects have been attributed to sirt1, and its activation, whether direct or indirect, may be sufficient to promote health span and life span (77).…”

Do Sirtuins Promote Mammalian Longevity?: A Critical Review on Its Relevance to the Longevity Effect Induced by Calorie Restriction

“…Resveratrol improved mitochondrial function and protected against high fat-induced obesity through SIRT1 and PGC1α (Lagouge et al, 2006). However, whether resveratrol and SRT1720 directly activate SIRT1 is still under debate, as SIRT1 activation by these compounds was induced only when a fluorophore tag was covalently attached to the peptide substrate, as in the initial compound screens (Borra et al, 2005;Kaeberlein et al, 2005;Pacholec et al, 2010). CR and resveratrol increase endothelial-derived nitric oxide (NO) (Csiszar et al, 2009;Nisoli et al, 2005), an important regulator of vascular relaxation and endothelial senescence (Oemar et al, 1998).…”